Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients

Heart Rhythm

Volumn 3, Issue 12, 2006, Pages 1397-1403

  Smit, Marcelle D ^a   Van Dessel, Pascal F H M ^a   Nieuwland, Wybe ^a   Wiesfeld, Ans C P ^a   Tan, Eng S ^a   Anthonio, Rutger L ^a   Van Erven, Lieselot ^b   Van Veldhuisen, Dirk J ^a   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Left ventricular ejection fraction; Right ventricular pacing

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; STATIN;

ADULT; AGED; ANAMNESIS; ANGINA PECTORIS; ARTICLE; CONFIDENCE INTERVAL; DEATH; DEFIBRILLATOR; DRUG USE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ANGINA PECTORIS; ARRHYTHMIA; ATRIAL FIBRILLATION; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 33845208808     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.08.006     Document Type: Article

References (24)

1. Ezekowitz J.A., Armstrong P.W., and McAlister F.A. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138 (2003) 445-452
2. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R., Fain E., Gent M., and Connolly S.J. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
4. Wilkoff B.L., Cook J.R., Epstein A.E., Greene H.L., Hallstrom A.P., Hsia H., Kutalek S.P., and Sharma A. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288 (2002) 3115-3123
5. Sharma A.D., Rizo-Patron C., Hallstrom A.P., O'Neill G.P., Rothbart S., Martins J.B., Roelke M., Steinberg J.S., and Greene H.L. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2 (2005) 830-834
6. Steinberg J.S., Fischer A., Wang P., Schuger C., Daubert J., McNitt S., Andrews M., Brown M., Hall W.J., Zareba W., and Moss A.J. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 16 (2005) 359-365
7. Saad E.B., Marrouche N.F., Martin D.O., Cole C.R., Dresing T.J., Perez-Lugones A., Saliba W., Schweikert R.A., Wilkoff B.L., Tchou P., and Natale A. Frequency and associations of symptomatic deterioration after dual-chamber defibrillator implantation in patients with ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 90 (2002) 79-82
8. Wonisch M., Lercher P., Scherr D., Maier R., Pokan R., Hofmann P., and Von Duvillard S.P. Influence of permanent right ventricular pacing on cardiorespiratory exercise parameters in chronic heart failure patients with implanted cardioverter defibrillators. Chest 127 (2005) 787-793
9. Wiesfeld A.C., Crijns H.J., Hillege H.L., Tuininga Y.S., and Lie K.L. The clinical significance of coronary anatomy in post-infarct patients with late sustained ventricular tachycardia or ventricular fibrillation. Eur Heart J 16 (1995) 818-824
10. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
11. Andersen H.R., Nielsen J.C., Thomsen P.E.B., Thuesen L., Mortensen P.T., Vesterlund T., and Pedersen A.K. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350 (1997) 1210-1216
12. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., Greenspon A.J., Freedman R.A., Lee K.L., and Lamas G.A. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
13. Nahlawi M., Waligora M., Spies S.M., Bonow R.O., Kadish A.H., and Goldberger J.J. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol 44 (2004) 1883-1888
14. Vernooy K., Dijkman B., Cheriex E.C., Prinzen F.W., and Crijns H.J. Ventricular remodeling during long-term right ventricular pacing following His bundle ablation. Am J Cardiol 97 (2006) 1223-1227
15. Connolly S.J., Kerr C.R., Gent M., Roberts R.S., Yusuf S., Gillis A.M., Sami M.H., Talajic M., Tang A.S.L., Klein G.J., Lau C., and Newman D.M. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 342 (2000) 1385-1391
16. Toff W.D., Camm A.J., and Skehan J.D. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 353 (2005) 145-155
17. Kindermann M., Hennen B., Jung J., Geisel J., Bohm M., and Frohlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction. The Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 7 (2006) 1927-1937
18. Vernooy K., Verbeek X.A., Peschar M., and Prinzen F.W. Relation between abnormal ventricular impulse conduction and heart failure. J Interv Cardiol 16 (2003) 557-562
19. Van Oosterhout M.F., Prinzen F.W., Arts T., Schreuder J.J., Vanagt W.Y., Cleutjens J.P., and Reneman R.S. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 98 (1998) 588-595
20. Prinzen F.W., Cheriex E.C., Delhaas T., Van Oosterhout M.F., Arts T., Wellens H.J., and Reneman R. Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J 130 (1995) 1045-1053
21. Adomian G.E., and Beazell J. Myofibrillar disarray produced in normal hearts by chronic electrical pacing. Am Heart J 112 (1986) 79-83
22. Lee M.A., Dae M.W., Langberg J.J., Griffin J.C., Chin M.C., Finkbeiner W.E., O'Connell J.W., Botvinick E., Scheinman M.M., and Rosenqvist M. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 24 (1994) 225-232
23. Tse H.F., and Lau C.P. Long-term effect of right ventricular pacing on myocardial perfusion and function. J Am Coll Cardiol 29 (1997) 744-749
24. Gregoratos G., Abrams J., Epstein A.E., Freedman R.A., Hayes D.L., Hlatky M.A., Kerber R.E., Naccarelli G.V., Schoenfeld M.H., Silka M.J., and Winters S.L. ACC/AHA/NASPE 2002 Guideline update for implantation of Cardiac Pacemakers and Antiarrhythmia Devices. Summary article: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker, Guidelines). J Cardiovasc Electrophysiol 13 (2002) 1183-1199